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Cancer is a major public health problem in the 
world and responsible for 13% of all deaths. 
Currently cancer is the third leading cause of death 
in Iran after coronary heart disease and accidents 
based on latest reports from the Ministry of Health 
and Medical Education (MOHME) (1). By ageing 
the population and reducing the number of death 
caused by accidents, cancer is becoming the second 
cause of mortality in Iran. Moreover, the incidence 
rate of almost all kinds of malignancies has 
alarmingly increased in the past two decades. It is 
estimated that more than 90,000 of new cancer cases 
occur annually in Iran, and it is assumed this number 
will double by the year 2020 (2).  
Cancer is the third leading cause of death in Iran following coronary 
heart disease and accidents. According to the estimate report from 
GLOBOCAN 2012, the age-standardized incidence rate (ASR) of 
cancers was 134 and 120 per 100,000 among males and females, 
respectively. The estimated mortality rate for cancer was 90.4 and 72.2 
per 100,000 for males and females, respectively that shows an increase 
of 25.4 and 31.1 percent compared to the latest report from National 
Death Registry (NDR) in 2004. The most common cancer among men 
and women was stomach cancer (20.6%) and breast cancer (28.1%), 
respectively and the most common childhood cancer was leukemia. 
Up-to-date and accurate cancer registry data could be one of the major 
determinants to control, classify, diagnose and even in the treatment of 
cancer cases. However, since 2009 no up-to-date formal reports from 
the National Cancer Registry (NCR) of Iran have been announced.  
Information from the cancer registries regarding different regions of 
Iran have been published in different articles. In this article, we 
collected all available data through literature review and further, 
visualize them in a way that could be more understandable. 
Additionally, we have provided the expected numbers of new cancer 
cases and deaths in 2008 and 2012 in Iran based on GLOBOCAN. Our 
survey revealed that there is an urgent need for a comprehensive 
cancer statistics registration to guide cancer policy-makers and 
researchers to make informed decisions that will improve health care.   
Keywords: Cancer  statistics, Cancer  therapy, Incidence, 
Mortality, Childhood  
Raheleh Amirkhah1,2, Hojjat Naderi-Meshkin2,3, Mahdi Mirahmadi2,3, Abolghasem 
Allahyari4, Hamid Reza Sharifi5,6* 
ABSTRACT 
www.thecancerpress.com 
Corresponding Author E-Mail: hamid.sharifi@ki.se                                                                                                                               27 
References 
 
1.  Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med. 2010 Mar;13
(2):143–6.  
2.  Isco A, Specialty M, Board T, Contact C, Isco J, Mail W. Iranian Society of Clinical Oncology ( ISCO ) Cancer in 
Iran Cancer in Iran. 2016;1–14.  
Vol. 3, No. 2, jun, 2017 
Vol 3, No 2, June, 2017, P 27-38 
DOI, 10.15562/tcp.42 
Statistical Report 
References 
 
3.  Maryam M, Ali-Akbar H, Eshagh D, Abbas B, Kazem Z. Completeness and underestimation of cancer mortality 
rate in Iran: a report from Fars province in Southern Iran. Arch Iran Med. 2015;18(3).  
4.  Mousavi SM, Alamolhoda AA, Gouya MM, Lickiss N. Implementation of Comprehensive National Cancer Control 
Program in Iran: an experience in a developing country. Vol. 19, Annals of oncology : official journal of the 
European Society for Medical Oncology / ESMO. England; 2008. p. 398–400.  
5.  Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality 
worldwide: sources, methods and major patterns in  GLOBOCAN 2012. Int J cancer. 2015 Mar;136(5):E359-86.  
6.  Azizi MH, Bahadori M, Azizi F. History of cancer in Iran. Arch Iran Med. 2013 Oct;16(10):613–22.  
7. Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, Bahadori M. Cancer registry in Iran: a brief overview. 
Arch Iran Med. 2008 Sep;11(5):577–80.  
8. 8.  Mohagheghi MA, Mosavi-jarrahi A. Review of Cancer Registration and Cancer Data in Iran , a Historical 
Prospect. 2010;11:1155–7.  
www.imaqpress.com  
Having efficient cancer and death registration 
systems are the main foundation of cancer control 
programs and provide crucial information for policy 
makers to find out about cancer epidemiology in 
each, in order to set priority and design 
comprehensive cancer prevention plans (3). 
However, there is an absence of functional cancer 
registries in Iran. Only a few national programs 
according to the World Health Organization (WHO) 
guidelines for cancer screening and prevention are 
active in Iran (4). 
The aim of this study is to provide the rather 
comprehensive and updated report of cancer 
incidence and mortality according to the available 
data. We also used GLOBOCAN (http://
globocan.iarc.fr) to get the estimated result of cancer 
incidence and mortality for years 2008 and 2012 (5).  
 
History of Cancer registry in Iran  
Collecting information concerning the incidence, 
type, and location of cancers is of prime interest to 
control the cancer burden; and this is best done in 
the framework of cancer registries. Cancer Registry 
is the systematic collection, storage and analysis of 
data on cancer cases usually done in a certain region 
and a specified population (6). 
The first cancer registry system in Iran was 
pathology based. Changes in the cancer registry 
system to a population based approach caused an 
increase of cancer registration. 
The first population-based cancer registry was 
established by University of Tehran and 
collaboration with the International Agency for 
Research on Cancer (IARC) in 1969 and started its 
activity in Mazandaran province. However, their 
efforts were interrupted in the early 1980s due to the 
sociopolitical events in Iran. In 1984, a bill was 
passed by the Parliament mandating the report of all 
tissues “diagnosed or suspected as cancer tissue” to 
the Ministry of Health. In 1998, Tehran Population-
Based Cancer Registry (TPBCR), also known as 
Tehran Metropolitan Area Cancer Registry 
(TMACR), started to collect data from cancer cases 
throughout the Tehran metropolis. In 1992, 
Digestive Disease Research Center (DDRC) was 
established in Tehran University of Medical 
Sciences. This center established a population-based 
cancer registry in 5 provinces namely Golestan, 
Ardebil, Kordestan, Kerman, and Khozestan. These 
five provinces have a total population of roughly 
10.8 million which is about 8% of the total 
population of Iran. All of these registries are now 
run by the local universities of medical sciences 
(7,8).   
 
Trends in Cancer Incidence Rates 
Incidence rate is the number of new cases in a 
defined period of time and in a specified population, 
which provides an approximation of the average risk 
of developing a cancer.  
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Figure 1 illustrates increasing trends of cancer 
incidence rates for all cancers from 2004 to 2012 by 
sex. Trends in overall incidence are heavily 
influenced by the 4 major cancers includes stomach, 
breast, prostate, and colorectal (Figure 3a). These 
cancers will be more considered in section 6.  
Some studies in different provinces of Iran reported 
significant increasing trend of cancer. For example, 
Vakili et al. reported the age standardized incidence 
rate (ASR) in female increase from 84.6 to 94.8 and 
in male from 85.9 to 113.8 during 2005 to 2009 (9).   
In another study conducted in Isfahan reported an 
increasing incidence rate from 2005 to 2010. They 
showed ASR changed from 107 in 2005 to 124.9 in 
2010 (10). Rafiemanesh's study carried out to 
investigate the cancer trends in Sistan and 
Baluchestan province during 2004 to 2009 showed 
an increasing incidence rate from 22.20 to 35.29 for 
females and 18.95 to 35.99 for males (11). 
Increasing in rate of cancer incidence, may be due to 
aging, air pollution and cancer associated lifestyle 
such as stress, physical inactivity, and smoking. In 
addition, improvement of registery system could 
also be another reason for increasing rate of 
incidence over this time. 
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Figure 1: Trends in cancer incidence rates by sex, Iran. The reported data from 2004 to 2006 is based on the NCR (12) and for 2008 and 
2012 are based on GLOBOCAN  
Trends in Cancer Mortality 
Mortality, the number of deaths occurring in a given 
period of time and in a defined population can be 
expressed as a rate per 100,000 persons per year.  
In addition to the cancer registry, data from the death 
registry could provide important information 
regarding the cancer control status (3). There are no 
publicly available reports of mortality in the NCR of 
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Iran, but the population-based cancer studies of five 
provinces took it into consideration (12). The 
National Death Registry (NDR) of Iran is in charge 
to register data on cancer death. However, due to 
lack of a computerized system for death registry and 
unique identification number, the cancer mortality 
reports presented among provinces in population-
based cancer registry are inconsistent. (12). 
According to the reports from Kolahdoozan et al. the 
estimated mortality rate for cancer was 41.1 and 65 
per 100,000 for females and males in 2004 
respectively (1).  
Based on GLOBOCAN there is an increased 
mortality rate caused by cancer in females from 61.8 
in 2008 to 72.7 in 2012. However, the estimated 
cancer death rate in males has been decreased from 
98.3 in 2008 to 90.4 in 2012.  Figure 2 shows a 
comparison of these data. 
Figure 2: Trends in cancer mortality rates, by sex, Iran for 2004 from NDR (12), 2008 and 2012 based on GLOBOCAN  
Estimated Number of Cancer Cases and Deaths in 
2012 
Over 14 million new cases and more than 8 million 
cancer deaths occurred in 2012 worldwide based on 
GLOBOCAN 2012. The contribution of developing 
countries was 56.9% for incidence and 64.9% for 
deaths. However, the future is more alarming. The 
total number of new cases is expected to increase by 
29% in developed countries whereas, in developing 
countries an increase of 73% is expected by 2020, as 
a result of changing dietary habits, ageing and 
urbanization (13). Among the cancers stomach, 
bladder, prostate, and colorectal cancers account for 
about one-half of all cases in men, while the most 
commonly diagnosed cancers in women are breast, 
colorectal, stomach, and esophagus, accounting for 
one-half of all cases in women. Breast cancer alone 
is expected to account for 24.5% of all new cancers 
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in women (Figure 3a). Notably stomach cancer has 
the highest rate of incidence among men and third 
highest among women in Iran. Lung cancer has also 
lower incidence rate in both gender as compared to 
its global incidence statistics.  
Figure 3b shows the expected numbers of deaths 
from cancer in 2012 in Iran. It was estimated that 
about 53350 Iranian died from cancer this year, 
corresponding to about 146 deaths per day. The most 
common causes of cancer death are cancers of the 
breast, stomach, esophagus, and colorectal in women 
and cancers of the stomach, lung, esophagus, and 
prostate in men.  
a 
b 
Figure 3 The estimated cancer cases and deaths by Sex. About 84,829 cancer cases and 53,350 cancer deaths were estimated in Iran, for 
the year 2012 
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Cancer in Children  
 
According to American Cancer Society (ACS), 
cancer is the third main reason for children’s 
mortality after injuries and unintentional deaths. 
ACS estimated that in 2016, 10,380 children aged 1 
to 14 years in the United States would be diagnosed 
with cancer and 1,250 children will die from the 
disease (14). 
The first report of childhood cancer in Iran was 
published in 1974. The national pathologic-based 
cancer registry which has been developed since 1984 
reported the incidence of childhood cancer about 60 
per million in 2006 (12). Since 1998 the cancer 
research center of cancer institute has started to 
collect cancer data in Tehran Metropolis by a 
population-based approach. This center reported an 
incidence of 144 for childhood cancer from 1998 to 
2001 (15). A population 
based cancer registry in Ardebil province reported 
an incidence rate of 50 for childhood cancer from 
1996 to 1999 (16). 
Mosavi-Jarrahi et al. reported an overall incidence 
rate of 176 per 1000,000 childhood cancer in Tehran 
during 1998 to 2002 (aged 0-15 years) (17). 
According to Golestan Population‐based Cancer 
Registry (GPCR) 5076 cancer cases were diagnosed 
in Golestan during 2004 to 2006. Of these, 139 (2.74 
%) were under 14 years old. Moradi et al. reported 
that the ASR rates for childhood cancer were 119.8 
and 78.3 per 1000,000 person‐years in male and 
female children, respectively (18).  
However, NCR reported 15.9 and 18.8 per million in 
females and males, respectively. This discrepancy 
might be due to many unreported diagnosed cancers 
cases by oncologists without sending the specimens 
to pathologic centers (12). 
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Figure 4: The most common childhood cancers in Golestan province/Iran (2004 - 2006) 
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According to available data, the most common 
childhood cancer were leukemia, lymphoma, and 
central nervous system (CNS) (19). The data from 
GPCR also shows the same result (See figure 4). 
Unfortunately, no official report about childhood 
cancer statistics was disclosed by the authorities in 
recent years. Based on statistics announced by the 
Mahak Charity Organization before 2008, 9 out of 
every 100,000 children have been diagnosed with 
cancer, however, this statistics has been raised from 
2008 onwards.  
 
Most Common Cancers in Iran  
Based on latest report from GLOBOCAN 2012, 
breast cancer in females and stomach cancer in 
males are the most frequently diagnosed cancers and 
the leading cause of cancer death in Iran. 
Figure 5 indicates the most common cancers 
expected to occur in men and women in 2012 based 
on GLOBOCAN. However, the pattern of cancer 
incidence is different in various geographical 
regions, mainly due to the differences in risk factor.  
For example, according to statistical studies 
conducted in Khuzestan province (20), between 
2002 and 2009, the top 5 highest ASRs in Iranian 
males were skin (16), bladder (10.7), prostate (7.64), 
stomach (7.17) and colorectal (6.32). These were 
breast (26.4), skin (13.6), colorectal (7.52), stomach 
(4.31) and bladder (4.07) in females (26).  
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Figure 5: Most common cancer by sex in Iran, 2012  
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Vakili et al. (2005 - 2009) indicated that the most 
prevalent cancers in Yazd province between 2005 to 
2009 were skin, bladder, colorectal, stomach and 
prostate in males and breast, skin, colorectal, gastric 
and leukemia in females (21). Rafiemanesh et al. 
presented a study based on the average ASR during 
2004 and 2009, and showed the most frequent 
cancers were gastric (3.72), skin (3.46), leukemia 
(2.24), esophagus (2.20) and bladder cancer (2.15) in 
males while the most common cancers in females 
were breast (4.77), esophagus (3.14), skin (2.95), 
colorectal cancers (1.91) and leukemia (1.53) (22) in 
Sistan and Baluchestan province. Of note, skin is 
one of the most common cancers in all mentioned 
studies. The main difference between the results 
reported in the present study with the previous 
studies mentioned above is skin cancer. Probably 
one of the most important risk factors for skin cancer 
is sunlight which is intense in Yazd, Khuzestan, and 
Sistan and Baluchestan. 
 
Breast Cancer 
Globally, breast cancer is the most common cancer 
afflicting women. Likewise in Iran, breast cancer is 
the most frequently diagnosed cancer and the 
leading cause of cancer death among females, 
accounting for 24.5% of the total cancer cases and 
14.2% of the total cancer deaths in 2012 (Figure 3). 
The trends of breast cancer incidence and mortality 
in Iran can be seen in figure 6. However, there is 
largely variation in incidence rates of breast cancer 
at international level which may be because of 
differences in reproductive patterns and hormonal 
factors and the availability of early detection 
services. Reproductive factors that increase risk 
include a long menstrual history, nulliparity, recent 
use of postmenopausal hormone therapy or oral 
contraceptives, and first childbirth at later ages 
(23). In addition, mammography screening can be 
another reason of increasing rate in breast cancer 
(24). 
 
Colorectal Cancer  
Colorectal cancer (CRC) is one of the most common 
cancer affecting 1.23 million individuals (9.7% of 
overall cancers) annually and is the fourth common 
cause of cancer deaths (8% of overall cancer deaths) 
worldwide (26).  
According to the GLOBOCAN 2012, CRC in Iran is 
the fourth cause of cancer after stomach, bladder, 
and prostate in men and second cause after breast in 
women with about 7200 new cancer cases (7.4% of 
overall cancers) and 4300 deaths (8% of overall 
cancer death) estimated to have occurred in both sex.  
Recent studies have shown a rapid rise in the 
incidence of colorectal cancer (CRC) in Iran (26,27). 
The line graph (Figure 7) illustrates the rate of CRC 
mortality for both sexes. Although, there is not any 
report about CRC mortality from NDR during 2004 
to 2012, based on the estimated data from 
GLOBOCAN 2012, the mortality trend is generally 
upwards.   
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Figure 6: The trends of breast cancer incidence and mortality in Iran. The estimated data is shown by dash line. a. The data for trends of 
breast cancer incidence reported by Iranian annual National Cancer Registration from 2003 till 2009 (24). The data for 2012 was estimat-
ed by GLOBOCAN. b. Increasing trends of breast cancer mortality reported by the Iranian MOHME from 1995 to 2004 (25). The data 
for 2008 and 2012 is according GLOBOCAN estimation, shown by dash line 
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Changing in lifestyle and eating habits, consuming 
less dietary fiber and more animal fat may explain 
the increased incidence of CRC in Iran (28). 
 
Stomach Cancer 
Stomach cancer is the fifth most common cancer and 
the third leading cause of cancer death in the world 
(30). A total of 989,600 new stomach cancer cases 
and 738,000 deaths are estimated to have occurred 
worldwide in 2012, accounting for 8% of the total 
cases and 10% of total deaths.  
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100,000. The estimated data is shown by dash line. 
Although stomach cancer incidence and mortality 
rates have decreased in developed countries (30), it 
shows a mild rising trend in Iran (Figure 8). 
Availability of refrigeration, fresh fruits and 
vegetables, and a decreased reliance on salted and 
preserved foods are the reasons of substantially 
decrease in stomach cancer. Other major 
determinants for the favorable trends are reductions 
in chronic H. pylori infection in most parts of the 
world (31). 
However, in Iran a couple of environmental factors, 
including smoking, air pollution, high salt 
consumption, diet with low levels of antioxidants 
may play a role in the pathogenesis of stomach 
cancer which requires further investigations (16). 
The figure 8 shows the incidence rate of stomach 
cancer for both sexes during 2000 to 2012. As 
shown, the incidence rate in men rises during 2000 
to 2004; over subsequent years the trend till 2008 is 
steadily upwards. Afterward there is a slight 
decrease in the rate and from 2009 to 2010 leveled 
off. Since 2010 there is not any updated data based 
on the NCR of Iran, however, based on the estimated 
data from GLOBOCAN 2012, the incidence rate 
dramatically decreased to 20.6 from 42.9 in 2010. 
According to GLOBOCAN 2012, stomach cancer 
was the most common cancer in men (ASR = 20.6), 
and the third most common cancer in women (ASR 
= 9.7). Generally, stomach cancer rates are about 
twice as high in males as in females (Figure 3a).  
According to published data (1) the north and 
northwest regions of Iran are at an increased risk of 
stomach cancer. Sadjadi et al. observed the highest 
incidence of stomach cancer in the province of Iran  
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are at an increased risk of stomach cancer. Sadjadi et 
al. observed the highest incidence of stomach cancer 
in the province of Ardebil with ASR = 49.1 and 
ASR = 25.4 in men and women, respectively (16). 
Role of computational tools in cancer registry 
system  
The massive amounts of biomedical data are stored 
in different formats and accessed through many 
interfaces. Data integration is a crucial task in cancer 
research, and data elements play a main role in this 
regard. Thus, the common data elements (CDEs) 
used in cancer research data capture and reporting 
need to be standardized. The CDEs included 
demographic data, clinical history, pathology data, 
and clinical outcome data including treatment, 
recurrence and vital status (32).  
Developing a database of metadata for medical data 
to establish common classification of data elements 
using vocabulary standards, ontology and semantic 
modeling methodology in cancer registry may 
improve cancer statistics reports to survey the 
incidence of cancer in Iran. 
For example, the Taiwan Cancer Common Data 
Element Project (TCCDEP) developed 40 data 
elements to annotate the cancer registry data 
collected and to facilitate convergence towards a 
common metadata standard in Taiwan cancer 
registry data using a set of open source software and 
tools, such as the caCORE SDK and caGrid (33). 
The Specialized Program of Research Excellence 
(SPORE) is another bioinformatics-supported 
system to incorporate data from various clinical, 
pathological, and molecular systems into a single 
architecture based on a set of CDEs that provides 
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semantic and syntactic interoperability of data sets 
(34,35). In order to optimize cancer registration 
system in Iran, it is essential to integrate it with 
proper information technology (IT) tools.  
 
Conclusion 
The data sources for this study were based on literature review and data presented in NCR and Globocan. Our 
study indicated that there is an increasing trend of cancer incidence in Iran. However, lack of high-quality 
data may affect the figures found in this study. Additionally, there is not a consistency between the results 
reported from different cancer registry systems. These differences may be result of different statistical and 
sampling methods, which are used. Since the prevalence of cancer risk factors such as aging, life style, food 
habits, pollution in Iran are high, it is expected that in the near future the numbers of cancer cases and burden 
of cancer will rise rapidly. Therefore, it is necessary to establish well-structured population-based cancer 
registries to develop a comprehensive national cancer control program as the first priorities for health policy 
makers. Otherwise, with seemingly and predictable increasing rate of cancer incidence the healthcare system 
could not overcome the demands regarding diagnosis and treatment. A considerable proportion of cancer 
burden may be prevented through implementing programs for air pollution control, national health services 
such as cancer detection in early stage, vaccination as well as health improvement programs regarding diet, 
physical activity, etc.  
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